During drug product development, the nature and distribution of the active substance have to be controlled to ensure the correct activity and the safety of the final medication. Matrix assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), due to its structural and spatial specificities, provides an excellent way to analyze these two critical parameters in the same acquisition. The aim of this work is to demonstrate that MALDI-MSI, coupled with four well known multivariate statistical analysis algorithms (PCA, ICA, MCR-ALS and NMF), is a powerful technique to extract spatial and spectral information about chemical compounds from known or unknown solid drug product formulations. To test this methodology, an in-house manufactured tablet and a commercialized Coversyl(®) tablet were studied. The statistical analysis was decomposed into three steps: preprocessing, estimation of the number of statistical components (manually or using singular value decomposition), and multivariate statistical analysis. The results obtained showed that while principal component analysis (PCA) was efficient in searching for sources of variation in the matrix, it was not the best technique to estimate an unmixing model of a tablet. Independent component analysis (ICA) was able to extract appropriate contributions of chemical information in homogeneous and heterogeneous datasets. Non-negative matrix factorization (NMF) and multivariate curve resolution-alternating least squares (MCR-ALS) were less accurate in obtaining the right contribution in a homogeneous sample but they were better at distinguishing the semi-quantitative information in a heterogeneous MALDI dataset.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2014.11.047DOI Listing

Publication Analysis

Top Keywords

statistical analysis
12
mass spectrometry
8
spectrometry imaging
8
drug product
8
multivariate statistical
8
component analysis
8
analysis
5
application chemometric
4
chemometric algorithms
4
algorithms maldi
4

Similar Publications

Background And Aims: Data on second generation basal insulin (2BI) in people with type 2 diabetes (T2D) generated by clinical trials still need confirmation in real-world clinical settings. This study aimed at assessing the comparative effectiveness of 2BI [Glargine 300 U/mL (Gla-300) vs. Degludec 100 U/mL (Deg-100)] in T2D Italian patients switching from first generation basal insulins (1BI).

View Article and Find Full Text PDF

Background: This study aims to investigate the predictive value of biological and neuroimaging markers to determine incident frailty among older people for a period of 5 years.

Methods: We included 1394 adults aged 70 years and older from the Multidomain Alzheimer Preventive Trial, who were not frail at baseline (according to Fried's criteria) and who had at least 1 post-baseline measurement of frailty. Participants who progressed to frailty during the 5-year follow-up were categorized as "incident frailty" and those who remained non-frail were categorized as "without frailty.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!